Table of Contents
Competitor Analysis: Kallikrein Inhibitors & Bradykinin Receptor Antagonists
The present Competitive Intelligence report about Kallikrein Inhibitors & Bradykinin Receptor Antagonists provides a competitor evaluation in the field of marketed and novel approaches for prophylaxis and treatment of hereditary angioedema (HAE) as of June 2014. Inhibitors of kallikrein and antagonists of the bradykinin receptors are based on small molecules, antibodies, proteins, peptides as well as RNA and their use is being extended to other diseases.
Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently active projects in research and development of small molecule, antibody, protein, peptide and oligonucleotide inhibitors or antagonists kallikrein or the bradykinin receptor, respectively. In addition, the report lists company-specific R&D pipelines of kallikerein inhibitors & bradykinin receptor antagonists. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Product Category,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Use this report to: - Identify key market dynamics and the factors impacting the global protein-labeling market and its subsegments. - Gain insight into global protein-labeling market and its market segments, ...
Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...
“The fruit & vegetable processing enzymes market projected to grow at a CAGR of 6.7%” The fruit & vegetable processing enzymes market is projected to reach USD 41.39 billion by 2022 at a CAGR of 6.7% ...